The Washington University Medical Center, located in St. Louis, Missouri, is a large scale health-care focused commercial development located in St. Louis' Central West End neighborhood.

During the past decade, Washington University Medical Center conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 31 clinical trials were completed, i.e. on average, 110.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 18 clinical trials were completed. i.e. 257.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Washington University Medical Center" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "Washington University School of Medicine" with 6 trials sponsored, "United Therapeutics" with 5 trials sponsored, "Abbott Medical Devices" with 3 trials sponsored and "Genzyme, a Sanofi Company" with 3 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Washington University Medical Center" #1 collaborator was "Washington University School of Medicine" with 5 trials as a collaborator, "Massachusetts General Hospital" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator and "Duke University" with 2 trials as a collaborator. Other collaborators include 83 different institutions and companies that were collaborators in the rest 89 trials.

According to Clinical.Site data, the most researched conditions in "Washington University Medical Center" are "Pulmonary Hypertension" (6 trials), "Amyotrophic Lateral Sclerosis" (2 trials), "Aortic Valve Stenosis" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Dopamine Beta Hydroxylase Deficiency" (2 trials). Many other conditions were trialed in "Washington University Medical Center" in a lesser frequency.

Most popular intervention types in "Washington University Medical Center" are "Drug" (50 trials), "Device" (12 trials), "Biological" (9 trials), "Procedure" (6 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Doxorubicin" (3 trials), "Olaratumab" (3 trials), "Abemaciclib" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Washington University Medical Center" are 71 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Washington University Medical Center". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 54 completed trials in Washington University Medical Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Washington University Medical Center, 14 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".